OMER | Omeros CorporationNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history

$18.27
+$0.44 (+2.47%)

Omeros Corporation (OMER) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2017.

The 50 SMA has sat above the 200 on the daily since Aug 2026, with no cross projected inside the 30 bars Cruxta tracks. On both the daily and the 4-hour, price sits between the 50 and the 200; on the weekly it is above both.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
between the two $18.27 vs 50 $18.47 / 200 $13.55
Projection
No cross projected
Test
No active test
Last cross
Golden cross 20 Aug 2026 ยท projected 30 bars out

Weekly as of 30 Oct 16:00 ET

Price
above both $18.44 vs 50 $13.10 / 200 $6.91
Projection
No cross projected
Test
No active test
Last cross
Golden cross week of 10 Mar 2025 ยท projected 24 bars out ยท tested 2 bars

4-hour as of 3 Nov 13:30 ET

Price
between the two $18.01 vs 50 $18.03 / 200 $15.13
Projection
No cross projected
Test
No active test
Last cross
Golden cross 14 Aug 2026 ยท projected 28 bars out

Cross history

36
crosses on record since 2017
19 golden17 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
20 Aug 2026Golden steepdaily30 bars outNot tested
14 Aug 2026Golden4-hour28 bars outNot tested
22 Jul 2026Death steepdaily16 bars out3 bar cross test
11 Jun 2026Death4-hour28 bars outNot tested
28 Apr 2026Golden4-hour27 bars outNot tested

About OMER

ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$21.8M
4-hour coverageYes, since Oct 2025
History on recordSince 2017
SectorHealthcare
Cap bandsmall

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.